Organisation paid for research Program year 2023 Source: CMS Open Payments

Vistar Inc

Neither a doctor nor a teaching hospital

Research payments

$173,458

8 payments

Through program year 2023, Vistar Inc is reported as receiving $173,458 in research payments, across 8 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$130,338	1
2022	Research	$40,735	4
2021	Research	$2,385	3

Breakdown

Who paid Research payments · program years 2021–2023

Otsuka Pharmaceutical Development & Commercialization, Inc. $130,338 1 payment
Grifols Therapeutics LLC $40,735 4 payments
Kowa Research Institute, Inc. $2,385 3 payments

Studies the money was for Research payments · program years 2021–2023

Extraction of real-time ADPKD outcomes from a large electronic health record dataset $130,338 1 payment
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor Human Plus Standard Medical Treatment SMT Versus Placebo Plus SMT in Hospitalized Subjects With $40,735 4 payments
K-877-302 $2,385 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.